BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 16890594)

  • 1. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
    Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
    Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
    Mawdsley JE; Jenkins DG; Macey MG; Langmead L; Rampton DS
    Am J Gastroenterol; 2008 Jun; 103(6):1460-9. PubMed ID: 18510607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
    Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
    Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
    Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
    Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis.
    Murata Y; Ishiguro Y; Itoh J; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():56-60. PubMed ID: 8563892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase.
    Masuda H; Iwai S; Tanaka T; Hayakawa S
    J Clin Lab Immunol; 1995; 46(3):111-23. PubMed ID: 8926619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
    Bernstein CN; Robert ME; Eysselein VE
    Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles.
    Yamamoto T; Maruyama Y; Umegae S; Matsumoto K; Saniabadi AR
    Dig Liver Dis; 2008 Apr; 40(4):253-9. PubMed ID: 18243079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of interleukin-1b and tumor necrosis factor--a by peripheral blood human mononuclear cells in active and inactive stages of ulcerative colitis.
    Nikolopoulou V; Katsakoulis E; Tsiotos P; Thomopoulos K; Salsaa B; Zoumbos N
    Z Gastroenterol; 1995 Jan; 33(1):9-12. PubMed ID: 7886987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-related peripheral neuroendocrine-immune interactions in women with ulcerative colitis.
    Langhorst J; Cobelens PM; Kavelaars A; Heijnen CJ; Benson S; Rifaie N; Dobos GJ; Schedlowski M; Elsenbruch S
    Psychoneuroendocrinology; 2007; 32(8-10):1086-96. PubMed ID: 17933470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis.
    Olsen T; Goll R; Cui G; Christiansen I; Florholmen J
    Cytokine; 2009 May; 46(2):222-7. PubMed ID: 19286392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis.
    Irving PM; Macey MG; Feakins RM; Knowles CH; Frye JN; Liyanage SH; Dorudi S; Williams NS; Rampton DS
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):283-9. PubMed ID: 18334871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.
    Inoue S; Matsumoto T; Iida M; Mizuno M; Kuroki F; Hoshika K; Shimizu M
    Am J Gastroenterol; 1999 Sep; 94(9):2441-6. PubMed ID: 10484006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
    Andoh A; Ogawa A; Kitamura K; Inatomi O; Fujino S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
    J Gastroenterol; 2004 Dec; 39(12):1150-7. PubMed ID: 15622478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.